Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$58.36 -0.48 (-0.82%)
At close: Oct 22, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Short-Term Debt issuances (2025)

Updated

Arrowhead Pharmaceuticals' Short-Term Debt issuances was $3.16 million in fiscal Q4 2025 (quarter ended Sep 30, 2025).

Analysis

Arrowhead Pharmaceuticals (ARWR) Short-Term Debt issuances (2025) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Short-Term Debt issuances at Arrowhead Pharmaceuticals came in at $10.26 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.28 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Arrowhead Pharmaceuticals 8.36 Bn 3.13 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.16 Mn
API Access

Arrowhead Pharmaceuticals Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=ARWR&period=max&api_key=YOUR_API_KEY